Catalyst Biosciences Inc. announced it has retained Perella Weinberg Partners as a financial advisor to assist the Company in exploring strategic alternatives.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.22 USD | +0.32% | -0.91% | +16.35% |
Feb. 21 | US natgas prices soar 10% from 3-1/2-year low as Chesapeake cuts output | RE |
Feb. 19 | Munich's mountains and tech tempt big banks from Frankfurt | RE |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.35% | 716M | |
+231.37% | 1.99B | |
-.--% | 1.72B | |
+45.50% | 1.54B | |
+0.80% | 1B | |
+1.90% | 978M | |
+41.91% | 872M | |
+5.03% | 674M | |
+1.25% | 660M | |
+0.00% | 637M |
- Stock
- Equities
- Stock Perella Weinberg Partners - Nasdaq
- News Perella Weinberg Partners
- Catalyst Biosciences Engages Perella Weinberg Partners to Assist the Company in Exploring Strategic Alternatives